North West Cancer Research earmarks multi-million pounds鈥� worth of cancer research funding at 91快活林
A charity dedicated to funding life-saving cancer research in North Wales has announced it will contribute 拢1.34 million to advancing cancer research at 91快活林.
has announced the funding to support a new Clinical Chair in Cancer Studies at the North-West Cancer Research Institute at the University which will also be part funded by Betsi Cadwaladr University Health Board.
The Clinical Chair will lead on a 拢1.8million worth of investment in translational cancer research in Wales, which has been provided by North West Cancer Research and the Betsi Cadwaladr University Health Board.
It includes provisions to fund the appointment of a Clinical Senior Lecturer, Postdoctoral Laboratory Manager and two PhD studentships for five years.
The funding will also allow for the purchase of consumables and equipment, helping place 91快活林 and Betsi Cadwaladr as centres of excellence for cancer research, attracting world-class researchers, scientists and clinicians.
91快活林 and Betsi Cadwaladr University Health Board have committed to fund both the Clinical Chair and Clinical Senior Lecturer posts beyond the first five years as permanent posts.
North West Cancer Research is the biggest charitable funder of life-saving cancer research at 91快活林 and it is committed to funding more than 拢7million worth of research over the next 5 years.
North West Cancer Research funding has boosted the understanding of cancers such as leukaemia, prostate and skin cancer. Most recently, it has funded fundamental research which looks at how cancer cells divide and the impact it has on tumour growth and treatment.
Dr Edgar Hartsuiker, Chairman of the Bangor North West Cancer Research Institute said: 鈥淣orth West Cancer Research and the Betsi Cadwaladr University Health Board, have earmarked this significant amount of funding, which will allow us to drive forward advances in cancer research here at Bangor.
鈥淭he Clinical Chair will be a landmark appointment and they will lead on the world-class research already underway here. We hope to be in a position to announce the new appointment in the next few months and we welcome applications from clinical academics with an excellent research track record from all over the world.鈥�
Dr Caroline Usborne, Clinical Director for Cancer Services at Betsi Cadwaladr University Health Board said: 鈥淭his funding will not only boost our research capacity here in North Wales, but will help us to recruit additional high quality clinicians to North Wales, which will have a direct impact on our cancer patients.鈥�
Professor Dean Williams, Head of 91快活林鈥檚 School of Medical Sciences said: 鈥淭he additional support from NWCR and Betsi Cadwaladr University Health Board for these new posts in the School of Medical Sciences at 91快活林 will enhance both the profile of cancer research and the provision of cancer services in North Wales.鈥�
Professor John G Hughes, Vice-Chancellor of 91快活林 said: 鈥淭his is a significant step in our long-standing relationship with NWCR and Betsi Cadwaladr University Health Board. It offers substantial benefits for cancer research in the University and for healthcare in north Wales.鈥�
Follow the link for more information on Bangor鈥檚 Clinical Chair in Cancer Studies:
Publication date: 14 September 2017